Richest man in Asia invests in Chromadex (Niagen), will own 20% of company
ChromaDex announced yesterday that it has entered into a stock purchase agreement for the sale of up to $25 million
Read moreChromaDex announced yesterday that it has entered into a stock purchase agreement for the sale of up to $25 million
Read moreElysium Health launched with much fanfare and articles laced with names of renowned institutes and researchers some 3 years ago.
Read moreElysium Health, a dietary supplement company founded by biologist Leonard Guarente, released its first results about the effect of a
Read moreFor some time I have been following testimonials of people with regards to the health benefits they experience by using
Read moreA team from the Department of Physiology and Institute for Diabetes, Obesity and Metabolism of Perelman School of Medicine, University
Read moreA team largely comprised out of researchers from the Washington University School of Medicine conducted a 12-month-long experiment in which
Read moreAn in-depth paper was released in Nature Communications this month with an impressive line up of researchers incl. Charles Brenner
Read moreCharles Brenner, PhD who discovered Nicotinamide Riboside over a decade ago and described that in this paper in 2004 has
Read moreThis week the thesis work behind for example the press releases “Nicotinamide Riboside increases the Co-enzyme NAD+ in Human Clinical
Read moreStem cell therapy research is becoming increasingly popular with results to show. In clinical trials, the use of mesenchymal stem cells
Read more